𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evaluation of the synergistic effect of insulin resistance and insulin-like growth factors on the risk of breast carcinoma

✍ Scribed by Alecia Malin; Qi Dai; Herbert Yu; Xiao-Ou Shu; Fan Jin; Yu-Tang Gao; Wei Zheng

Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
86 KB
Volume
100
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

BACKGROUND

The purpose of the current study was to investigate the association between insulin resistance (which was measured using fasting blood C‐peptide) and its joint association with insulin‐like growth factors (IGF‐1, IGF‐2, and IGF binding protein‐3 [IGFBP‐3]) on the risk of breast carcinoma.

METHODS

Included in the current study were 400 case–control pairs from the Shanghai Breast Cancer Study. Pretreatment biospecimens and interview data were collected from all breast carcinoma cases and their individually matched controls.

RESULTS

Breast carcinoma risk was found to be statistically significantly increased when higher blood levels of C‐peptide and IGFs were noted in a dose‐response manner. There was a statistically significant twofold to threefold increased risk of breast carcinoma for women in the highest quartile of C‐peptide, IGF‐1, or IGFBP‐3 compared with women in the lowest quartiles. Women with high levels of both C‐peptide and IGF‐1 or IGFBP‐3 also were found to have a substantially higher risk of breast carcinoma than those women with a high level of only one of these molecules. The adjusted odds ratios (ORs) were 3.79 (95% confidence interval [95% CI], 2.03–7.08) for those with a higher level of both C‐peptide and IGF‐1 and 4.03 (95% CI, 2.06–7.86) for those with a higher level of both C‐peptide and IGFBP‐3.

CONCLUSIONS

The results of the current study suggest that insulin resistance and IGFs may synergistically increase the risk of breast carcinoma. Cancer 2004;100:694–700. © 2004 American Cancer Society.

📜 SIMILAR VOLUMES

Insulin-like growth factor-I, insulin-li
Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and the risk of fibrocystic breast conditions among Chinese women
✍ Chu Chen; Jennifer A. Doherty; S. Kay Lewis; Roberta M. Ray; Dao Li Gao; Helge S 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 94 KB 👁 1 views

## Abstract We investigated whether circulating insulin‐like growth factor‐I (IGF‐I) and insulin‐like growth factor binding protein‐3 (IGFBP‐3) levels are associated with the risk of fibrocystic breast conditions (FBC), in a case‐control study nested within a randomized trial of breast self‐examina

Serum insulin-like growth factor-I, insu
Serum insulin-like growth factor-I, insulin-like growth factor binding protein-3, and the risk of pancreatic cancer death
✍ Yingsong Lin; Akiko Tamakoshi; Shogo Kikuchi; Kiyoko Yagyu; Yuki Obata; Teruo Is 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 75 KB 👁 1 views

## Abstract Recent epidemiological studies have shown that high serum levels of insulin‐like growth factor‐I (IGF‐I) are associated with an increased risk of lung, colon, breast and prostate cancer. Since very few studies have addressed the role of serum levels of IGF‐I in the development of pancre

Premenopausal levels of circulating insu
Premenopausal levels of circulating insulin-like growth factor I and the risk of postmenopausal breast cancer
✍ Dana E. Rollison; Craig J. Newschaffer; Yuzhen Tao; Michael Pollak; Kathy J. Hel 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 94 KB 👁 1 views

## Abstract Increased levels of insulin‐like growth factor I (IGF‐I) may directly stimulate breast cell proliferation and promote growth and survival of transformed cells. Higher levels of IGF‐I have been associated with increased risk of premenopausal breast cancer but not postmenopausal breast ca

A sequence repeat in the insulin-like gr
A sequence repeat in the insulin-like growth factor-1 gene and risk of breast cancer
✍ Stacey A. Missmer; Christopher A. Haiman; David J. Hunter; Walter C. Willett; Gr 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 90 KB 👁 1 views

## Abstract Insulin‐like growth factor‐1 (IGF‐I), a potent mitogen, is hypothesized to influence breast cancer risk. In 3 previous studies, a polymorphism in the __IGF‐1__ gene (sequence repeat length) was associated with plasma IGF‐I level. We evaluated prospectively the relationships among a (CA)

Insulin-like growth factor family in mal
Insulin-like growth factor family in malignant haemangiopericytomas: the expression and role of insulin-like growth factor I receptor
✍ Paveli?, Kre?imir; Paveli?, Zlatko P.; Cabrijan, Tomislav; Karner, Ivan; Samar?i 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB 👁 2 views

Haemangiopericytoma is a rare soft tissue tumour originating from the contractile pericapillary cells. Relatively little is known about its molecular pathogenesis. To address this issue, the insulin-like growth factor family (IGFs) was analysed in 19 tumours collected from a human tumour bank networ